Results 1 to 10 of about 53,254,105 (402)

Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
Background Novel public health interventions are needed to address the toxic drug supply and meet the needs of people who use drugs amidst the overdose crisis.
Annie Foreman-Mackey   +5 more
doaj   +1 more source

Factors associated with willingness to wear an electronic overdose detection device

open access: yesAddiction Science & Clinical Practice, 2019
Background North America is in the midst of an opioid overdose epidemic. Although take-home naloxone and other measures have been an effective strategy to reduce overdoses, many events are unwitnessed and mortality remains high amongst those using drugs ...
Keith Ahamad   +6 more
doaj   +1 more source

When it comes to assessing the impact of e-cigarettes, estimates of device prevalence matter: the BIDI Stick disposable device

open access: yesHarm Reduction Journal, 2023
Background While e-cigarettes have been identified as an effective means of tobacco harm reduction, the degree to which these devices will realise their harm reduction potential will be determined in large part by how available these products are to ...
Neil McKeganey   +3 more
doaj   +1 more source

DSM-5 criteria for substance use disorders: recommendations and rationale. [PDF]

open access: yes, 2013
Since DSM-IV was published in 1994, its approach to substance use disorders has come under scrutiny. Strengths were identified (notably, reliability and validity of dependence), but concerns have also arisen.
Auriacombe, Marc   +11 more
core   +1 more source

Internalizing Symptoms, Peer Substance Use, and Substance Use Initiation [PDF]

open access: yesJournal of Research on Adolescence, 2015
This study used longitudinal survey and social network data covering sixth through ninth grades to test whether internalizing symptoms make early adolescents more prone to (1) exposure to and (2) influence by substance‐using peers. Random effects regressions revealed that increases in symptoms were significantly associated with increases in the ...
Sonja E. Siennick   +3 more
openaire   +3 more sources

Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study

open access: yesHarm Reduction Journal, 2021
Background Drug checking is a harm reduction intervention aiming to reduce substance use-related risks by improving drug user knowledge of the composition of unregulated drugs.
Tara Beaulieu   +6 more
doaj   +1 more source

Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project

open access: yesHarm Reduction Journal, 2023
Background The adulteration of the illicit drug supply with fentanyl and its analogues is driving the ongoing overdose crisis in North America. While various harm reduction interventions address overdose-related risks, there is growing interest in safer ...
Manal Mansoor   +3 more
doaj   +1 more source

Women’s multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study

open access: yesBMC Women's Health, 2021
Background North America is amidst an opioid overdose epidemic. In many settings, particularly Canada, the majority of overdose deaths occur indoors and impact structurally vulnerable people who use drugs alone, making targeted housing-based ...
Geoff Bardwell   +3 more
doaj   +1 more source

Substance Use and Depression Symptomatology: Measurement Invariance of the Beck Depression Inventory (BDI-II) among Non-Users and Frequent-Users of Alcohol, Nicotine and Cannabis [PDF]

open access: yes, 2016
Depression is a highly heterogeneous condition, and identifying how symptoms present in various groups may greatly increase our understanding of its etiology.
Moore, Ashlee A.   +3 more
core   +9 more sources

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

open access: yesAddiction Science & Clinical Practice, 2022
Background The COVID-19 pandemic and consequent public health response may have undermined key responses to the protracted drug poisoning crisis, including reduced access to opioid agonist therapy (OAT) among people with opioid use disorder.
Soroush Moallef   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy